In rectal cancer management, the main application of radiotherapy (RT) is in the neoadjuvant setting in Stage III (T3-4, node positive) and selected Stage II cancers.
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.